doi: 10.1186/s12944-018-0939-6, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 137
The second trial used a day cream, night cream, and serum, all with a 1% urolithin A concentration, and found that the treatment led to significant wrinkle reduction in participants
The FDA published a 68-page review of BPC-157, and they found one clinical trial across the whole orthopedic literature: 17 patients, who received BPC-157 mixed with a second peptide
Symptoms include: Diarrhea (typically watery but not bloody) Low-grade fever Nausea Occasional muscle aches or headache Stomach cramps and pain Vomiting The vomiting and diarrhea are the largest concerns, as patients can quickly become dehydrated
Treatment results can be enhanced by using nanoparticles to deliver anti-inflammatory medications straight to the inflammatory tissue
Sharps Container: Sharps containers can be used for disposing of excess syringes and needles